Exosome Diagnostic Market worth $2.9 billion by 2030, growing at a CAGR of 29.4% – Exclusive Report by Allied Market Research

Allied Market Research published a report, titled, “the global exosome diagnostic and therapeutic industry was estimated at $224.34 million in 2020, and is anticipated to hit $2.9 billion by 2030, registering a CAGR of 29.4% from 2021 to 2030″.

Alarming rise in prevalence of cancer & infectious disease and increase in number of approval for exosome therapeutics & diagnostics are expected to notably contribute toward the growth of the global exosome diagnostic & therapeutic market during the forecast period.

Key Takeaways:

• The diagnostic segment to dominate by 2030
• The instrument segment to maintain the lion’s share
• Pharmaceutical and biopharmaceutical sector across the province. Asia-Pacific, however, would grow at the fastest CAGR of 30.3% by 2030.

Request Sample Copy of the Report: 

https://www.alliedmarketresearch.com/request-sample/1723

Covid-19 scenario-

• Rapid spread of Covid-19 heightened the need for molecular diagnosis, thus impacting the global exosome diagnostic and therapeutic market positively.
• This trend is pretty likely to continue till the pandemic is completely over.

Major Factors Driving the Growth of Exosome Diagnostic and Therapeutic Market:

1. Rising Prevalence of Chronic Diseases:

• The increasing prevalence of chronic diseases such as cancer, Alzheimer’s disease, Parkinson’s disease, and autoimmune disorders is a major driver of the market.
• Exosomes have shown promising potential for early diagnosis and personalized treatment of these diseases.

2. Technological Advancements:

• Significant advancements in exosome isolation, characterization, and engineering are enabling the development of more accurate and reliable diagnostic tests and targeted therapeutic strategies.
• These advancements include:
  • Development of microfluidic devices for efficient exosome isolation.
  • Advancements in mass spectrometry and next-generation sequencing for exosome identification and characterization.
  • Engineering exosomes for targeted drug delivery and therapeutic applications.

3. Growing Recognition of Exosomes as Biomarkers:

• Exosomes are increasingly recognized as valuable biomarkers for disease diagnosis, prognosis, and monitoring.
• Their unique properties, such as stability, cell-type specificity, and cargo content, make them ideal candidates for non-invasive and specific disease detection.

Market Segmentation:

By Application:

• Diagnostic
• Therapeutic

By Product:

• Instrument
• Reagent
• Software

By End User:

• Cancer Institute
• Hospital
• Diagnostic Center
• Others

By Region:

• North America (U.S., Canada, Mexico)
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (Japan, China, Rest of Asia-Pacific)
• LAMEA (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Request for Customization: 

https://www.alliedmarketresearch.com/request-for-customization/1723

North America held the major share in 2020, generating nearly two-fifths of the global exosome diagnostic and therapeutic market, due to rise in product launches for exosome therapeutics, surge in the presence of key players, and development of R&D activities in the pharmaceutical and biopharmaceutical sector across the province. Asia-Pacific, however, would grow at the fastest CAGR of 30.3% by 2030. Increase in the prevalence of chronic and infectious disorders, growth in health care expenditures, and surge in demand for molecular diagnosis drive the market growth in the region.

Key players in the industry-

• Exosome Diagnostics Inc.
• NanoSomix Inc.
• Thermo Fisher Scientific Inc.
• Malvern Instruments Ltd.
• System Biosciences Inc.
• NX Pharmagen
• Aethlon Medical, Inc.
• Sistemic Inc.

Key Questions Answered in the Intelligent Study

What is the market size and growth rate of the global and regional market by various segments?
What is the market size and growth rate of the market for selective countries?
Which region or sub-segment is expected to drive the market in the forecast period?
What Factors are estimated to drive and restrain the market growth?
What are the key technological and market trends shaping the market?
What are the key opportunities in the market?
What are the key companies operating in the market?
Which company accounted for the highest market share?

Ask to Our Industry Expert: 

https://www.alliedmarketresearch.com/purchase-enquiry/1723

Why Choose Allied Market Research?

Industries’ Best Analysts
Exclusive Product Offerings
Customer Research Services
Dynamics Research Methodology
Comprehensive Reports
Latest Technological Advancements
Value Chain Analysis
Future Market Opportunities
Market Growth Dynamics
Quality Assurance
Post-sales Support
Continuous Report Update

Market Dynamics and Transformations

Economic Downturn Analysis: Impact of Recession in 2023
Pandemic’s Influence: Impact of Covid-19 Pandemic
Market Evolution: Recent Developments in the Market with Key Players Announcements.

Trending Reports in Healthcare Industry (Book Now with 20% Discount):

Arthroscopy Devices Market: https://www.alliedmarketresearch.com/arthroscopy-devices-market

Pharmacy Automation System Market: https://www.alliedmarketresearch.com/pharmacy-automation-systems-market

Transdermal Drug Delivery Systems Market: https://www.alliedmarketresearch.com/transdermal-drug-delivery-systems-market

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.